Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
Sareddy, G R, Viswanadhapalli, S, Surapaneni, P, Suzuki, T, Brenner, A, Vadlamudi, R K
Published in Oncogene (27.04.2017)
Published in Oncogene (27.04.2017)
Get full text
Journal Article
Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor
Nair, H.B, Santhamma, B, Viswanadhapalli, S, Sareddy, G.R, Manthati, V, Vadlamudi, R.K, Nickisch, K.J
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
63 - Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor
Nair, H.B., Santhamma, B., Viswanadhapalli, S., Sareddy, G.R., Manthati, V., Vadlamudi, R.K., Nickisch, K.J.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Abstract P4-07-01: A small molecule inhibitor (ERX-41) induces endoplasmic reticulum stress in triple negative breast cancer
Liu, X, Viswanadhapalli, S, Ma, S, Lee, T-K, Sareddy, GR, Ekoue, DN, Blatt, EM, Zhou, M, Li, M, Tekmal, RR, Ahn, J-m, Vadlamudi, RK, Raj, GV
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P1-09-06: Blocking ER coregulator signaling enhances CDK4/6 inhibitor palbociclib therapy in ER-positive advanced breast cancer
Viswanadhapalli, S, Sareddy, GR, Zhou, M, Ali, E, Li, X, Ma, S-H, Lee, T-K, Tekmal, RR, Ahn, J-M, Raj, GV, Vadlamudi, RK
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P5-04-23: Enhancing the activity of a novel estrogen receptor coregulator binding modulator (ERX-11) against ER-positive therapy resistant breast cancer
Viswanadhapalli, S, Ma, S, Lee, T-K, Sareddy, GR, Liu, X, Ekoue, D, Alluri, A, Luo, Y, Kassees, K, Arteaga, C, Alluri, P, Weintraub, SE, Tekmal, RR, Ahn, J-M, Raj, GV, Vadlamudi, RK
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer
Viswanadhapalli, S, Luo, Y, Sareddy, GR, Santhamma, B, Zhou, M, Li, M, Pratap, UP, Altwegg, KA, Li, X, Srinivasan, U, Ma, S, Chang, A, Riveros, AC, Zhang, KY, Dileep, KV, Pan, X, Murali, R, Bajda, M, Raj, G, Brenner, A, Manthati, V, Rao, M, Tekmal, RR, Nair, HB, Nickisch, KJ, Vadlamudi, RK
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P1-04-03: Cross-talk between RNA methyltransferase and demethylase regulates breast cancer growth and progression
Subbarayalu, P, Eedunuri, VK, Timilsina, S, Rajamanickam, S, Viswanadhapalli, S, Abdelfattah, N, Onyeagucha, BC, Cui, X, Mohammad, TA, Huang, TH-M, Huang, Y, Chen, Y, Rao, MK
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract S3-04: ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer
Vadlamudi, RK, Sareddy, GR, Viswanadhapalli, S, Lee, T-K, Ma, S-H, Lee, WR, Mann, M, Krishnan, SR, Gonugunta, V, Strand, DW, Tekmal, RR, Ahn, J-M, Raj, GV
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article